Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 69
Titolo Data di pubblicazione Autore(i) File
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 2016 Saccardi, R; Barilaro, A; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Innocenti, C; Mariottini, A; Nozzoli, C; Portaccio, E; Repice, AM; Amato, MP; Massacesi, L
Time Course of Multiple Sclerosis Lesions Visualized with MRI: Insight into Focal Pathology 2016 Maggi, P; Zellini, F; Barilaro, A; Passeri, A; Massacesi, L
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 2016 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L.
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 2016 Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study 2016 Scarpino, Maenia; Lolli, Francesco; Carrai, Riccardo; Lanzo, Giovanni; Spalletti, Maddalena; Barilaro, Alessandro; Fattapposta, Francesco; Amantini, Aldo; Grippo, Antonello
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 2016 Saccardi, R; Repice, AM; Innocenti, C; Mariottini, A; Amato, MP; Guidi, S; Fani, A; Nistri, R; Giannini, M; Portaccio, E; Barilaro, A; Nozzoli, C; Gozzini, A; Massacesi, L
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L
A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency 2017 Paganini, I.; Sestini, R.; Capone, G. L.; Putignano, A. L.; Contini, E.; Giotti, I.; Gensini, F.; Marozza, A.; Barilaro, A.; Porfirio, B.; Papi, L.
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 2017 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A
Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation. 2017 Palterer B, ,Sieni E, Barilaro A, Parronchi P
MMP9 index as possible diagnostic marker of Neuro-Behcet's disease 2017 Aldinucci, A (Aldinucci, A.); Bonechi, E (Bonechi, E.); Barilaro, A (Barilaro, A.); Repice, A (Repice, A.); Biagioli, T (Biagioli, T.); Massacesi, L (Massacesi, L.); Emmi, G (Emmi, G.); D'elios, MM (D'elios, M. M.); Ballerini, C (Ballerini, C.)
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy 2018 Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases 2018 Spinicci, Michele; Emmi, Giacomo; Dies, Laura; Barilaro, Alessandro; Vitiello, Gianfranco; Mencarini, Jessica; Cavallo, Annalisa; Bartoloni, Alessandro; Bartalesi, Filippo*
Natural history of brain inflammatory lesions in multiple sclerosis: a FLAIR and T1w post contrast MRI volumetric analysis 2018 Maggi, P; Zellini, F; Passeri, A; Barilaro, A; Massacesi, L
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 2018 Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 2018 Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L.
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 2018 Aldinucci A, Bonechi E, Biagioli T, Repice AM, D'Elios MM, Emmi L, Emmi G, Silvestri E, Barilaro A, Ballerini C
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 2018 Innocenti, C; Amato, MP; Barilaro, A; Bianchini, G; Capobianco, T; Calia, MA; Ceschini, R; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Rossolini, G; Saccardi, R
POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY: AN OBSERVATIONAL STUDY 2019 Mata, S; Barilaro, A; Massacesi, L; Sorbi, S
Mostrati risultati da 21 a 40 di 69
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile